Fever and Neutropenia in Pediatric Oncology Patients
Status:
Withdrawn
Trial end date:
2009-04-03
Target enrollment:
Participant gender:
Summary
It is possible to distinguish between pediatric oncology patients who are at high or low risk
for serious infection during periods of fever and treatment related neutropenia based on
clinical parameters. Patients with low risk can be safely treated as outpatients primarily
using oral antibiotics. It is possible to improve methods of risk stratification through the
addition of genomic and proteomic factors.